Int J Angiol 2012; 21(03): 129-134
DOI: 10.1055/s-0032-1324735
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Fibrin Sheath Angioplasty: A Technique to Prevent Superior Vena Cava Stenosis Secondary to Dialysis Catheters

Robert I. Hacker
1   Division of Vascular Surgery, North Shore-Long Island Jewish Health System, Manhasset, New York
,
Lorena De Marco Garcia
1   Division of Vascular Surgery, North Shore-Long Island Jewish Health System, Manhasset, New York
,
Ankur Chawla
1   Division of Vascular Surgery, North Shore-Long Island Jewish Health System, Manhasset, New York
,
Thomas F. Panetta
1   Division of Vascular Surgery, North Shore-Long Island Jewish Health System, Manhasset, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
19 August 2012 (online)

Preview

Abstract

Fibrin sheaths are a heterogeneous matrix of cells and debris that form around catheters and are a known cause of central venous stenosis and catheter failure. A total of 50 cases of central venous catheter fibrin sheath angioplasty (FSA) after catheter removal or exchange are presented. A retrospective review of an outpatient office database identified 70 eligible patients over a 19-month period. After informed consent was obtained, the dialysis catheter exiting the skin was clamped, amputated, and a wire was inserted. The catheter was then removed and a 9-French sheath was inserted into the superior vena cava, a venogram was performed. If a fibrin sheath was present, angioplasty was performed using an 8 × 4 or 10 × 4 balloon along the entire length of the fibrin sheath. A completion venogram was performed to document obliteration of the sheath. During the study, 50 patients were diagnosed with a fibrin sheath, and 43 had no pre-existing central venous stenosis. After FSA, 39 of the 43 patient's (91%) central systems remained patent without the need for subsequent interventions; 3 patients (7%) developed subclavian stenoses requiring repeat angioplasty and stenting; 1 patent (2.3%) developed an occlusion requiring a reintervention. Seven patients with prior central stenosis required multiple angioplasties; five required stenting of their central lesions. Every patient had follow-up fistulograms to document long-term patency. We propose that FSA is a prudent and safe procedure that may help reduce the risk of central venous stenosis from fibrin sheaths due to central venous catheters.